儿童致死性食物过敏反应:英国的法定审查。

IF 5.2 2区 医学 Q1 ALLERGY Clinical and Experimental Allergy Pub Date : 2025-01-07 DOI:10.1111/cea.14614
Sylvia Stoianova, Vibha Sharma, Robert J. Boyle
{"title":"儿童致死性食物过敏反应:英国的法定审查。","authors":"Sylvia Stoianova,&nbsp;Vibha Sharma,&nbsp;Robert J. Boyle","doi":"10.1111/cea.14614","DOIUrl":null,"url":null,"abstract":"<p>Fatal anaphylaxis is a very rare, unpredictable tragedy. For children and young people, most fatal anaphylaxis is caused by food allergy, and thus, carers of children and young people with food allergy may become preoccupied about the possibility of sudden, unexpected fatal anaphylaxis. Other unexpected causes of death such as severe acute asthma are less rare than fatal anaphylaxis, but the rapidity of fatal food anaphylaxis and its propensity to affect adolescents and young adults generate continued concern and societal interest.</p><p>The burden of avoiding known food allergens falls largely on people living with allergies and their families. Thus, an exposure leading to a fatal anaphylactic reaction may inspire fear and guilt in families and also in other carers, caterers and health professionals. Most anaphylactic reactions to food self-revert, with or without medical intervention [<span>1</span>]. In the past 30 years, several society-wide changes have been made to try to prevent fatal food anaphylaxis. In many countries such as the UK, these include widespread provision of adrenaline autoinjectors, new food allergen labelling laws, increased food allergy diagnostics and improved emergency service awareness of anaphylaxis and its management [<span>2, 3</span>]. Yet, fatal food anaphylaxis remains as common as it was 30 years ago, suggesting we need to go back a step and learn more about the condition [<span>4</span>]. Fatal food anaphylaxis is difficult to study prospectively, because it is very rare, unpredictable and usually occurs in the community. It is therefore important that we learn as much as we can from each tragic occurrence, and the recent statutory review of childhood fatal anaphylaxis and asthma provides an opportunity to do this (Figure 1, Table 1).</p><p>England is one of very few countries with a national, statutory, multi-professional review of all child deaths [<span>5</span>]. Since 2019, the National Child Mortality Database (NCMD) collates and analyses information about child deaths. For all deaths under age 18, a comprehensive summary of the circumstances of death and background information from professionals is collated. A final record summarises conclusions of a multi-agency panel documenting contributory, modifiable factors and learning. The latest NCMD thematic report analysed child deaths in England because of asthma or anaphylaxis. It identified key findings and made recommendations for policy, practice and research [<span>6</span>].</p><p>The report documents 54 child deaths from asthma and 19 from anaphylaxis in a 4-year period from 1 April 2019 to 31 March 2023. Many (54%) of the children who died from asthma also had a food allergy. However, the cause of death in these cases was thought to be asthma rather than food anaphylaxis. Fatal anaphylaxis was triggered by food allergy (<i>n</i> = 18) and in one case by anaesthesia, a rare cause of fatal anaphylaxis in childhood [<span>7</span>]. Just over half of fatal anaphylactic events occurred at the child's home or another private residence (friend or relative's home), 26% occurred in a public place, 11% at school, one at hospital and one abroad. Just under half the children who died from food anaphylaxis attended an emergency department at least once in the year prior to their death. In 16% of emergency department attendances in the previous year, the primary diagnosis for the attendance was anaphylaxis and in 11% asthma. Twenty-one per cent of fatal anaphylaxis cases also had at least one emergency inpatient admission in the year prior to their death, in three cases for asthma. The child death review process was complete for 12 children with fatal food anaphylaxis. From the completed reviews, the causative food allergen was only established in nine cases, with cow's milk and nuts the commonest, consistent with previous findings. These data build on a previous analysis of fatal food anaphylaxis in the UK between 1998 and 2018, and show a similar event rate to those years [<span>8</span>]. Although it is not possible to directly compare both analyses, as the data sources were different, there is no obvious sign that the number of fatal food anaphylaxis cases is changing over time [<span>4</span>]. Cases remain rare, however what the national analysis of child deaths can add is the identification of potentially modifiable contributory factors that if addressed with local or national interventions, may prevent future deaths in similar circumstances. This is at the heart of the value that a standardised child death process aims to bring.</p><p>One of the most significant findings in the NCMD report is that all 18 cases of fatal food anaphylaxis occurred in children who were known to have asthma. Only about half of children with food allergy have asthma, so asthma appears to be an important risk factor for fatal food anaphylaxis. Bronchospasm is also a dominant feature of food anaphylaxis and is likely to play an important part in the pathophysiology of fatal food anaphylaxis. The report also found that ingestion of the relevant allergen was not obvious in most cases. So, an important learning point from the analysis is that anaphylaxis should always be considered in a child with asthma and a known food allergy who has sudden breathing difficulty. In the absence of careful enquiry considering the possibility of an allergic reaction preceding death, fatal anaphylaxis as the cause of death may be missed.</p><p>The most common, potentially modifiable factors in cases of fatal food anaphylaxis were poor asthma control, lack of formal asthma diagnosis, poor communication around allergies, poor record-keeping and information-sharing between professionals and lack of access to effective emergency treatment. Most (89%) of those where the food allergen trigger was clear already knew they were allergic to the trigger allergen. There was limited information recorded about adrenaline autoinjector (AAI) use. Although these may not be effective for preventing fatal anaphylaxis, they are the current standard for self-administered emergency management of anaphylaxis [<span>4</span>]. There was lack of understanding of the role of emergency medicines, lack of availability of in-date emergency medications and lack of understanding about when and how to use them.</p><p>The most common public safety factors which were identified related to unclear, misleading or inaccurate labelling of food, either packaged or cooked, purchased from supermarkets or takeaway shops. In one case, there was presumed contamination of a packaged food which was opened and served at a public venue. Food suppliers and those serving customers, must ensure compliance with food labelling and handling regulations. Mast cell tryptase can be normal in cases of fatal anaphylaxis. However, a paired sample of mast cell tryptase in the context of a clinical presentation of anaphylaxis, can be informative in supporting investigation. The report found that there were instances where the mast cell tryptase test was not checked, collected without information regarding time of sample collection or only collected at the time of the post-mortem examination, reducing its usefulness [<span>9</span>].</p><p>A final, important recommendation from the report is that for all cases of fatal anaphylaxis the Joint Agency Response (JAR) to Suspected Child Death from Anaphylaxis or Asthma guidance, which supplements standard JAR guidance, should be followed. This covers mast cell tryptase testing in cases of suspected anaphylaxis, forensic investigation of potential sources of allergen for testing and collection of food packaging where food allergy is a possible cause. JAR is a mechanism for investigating unexpected child death, and it includes medical and forensic investigations, environmental assessment and post-mortem examination. If the specific JAR guidance is followed, this will help us learn about fatal food anaphylaxis in a more systematic way, with a view to providing evidence-based advice for families and health professionals in the future.</p><p>In conclusion, this new report which summarises 4 years of fatal anaphylaxis data for children in England gives important insights. The report highlights potentially modifiable risks in terms of asthma recognition and management, and communication related to food allergens. There is no evidence for a recent change in event rate. But by calling for more thorough and systematic investigation of every case of fatal food anaphylaxis, the report has the potential to trigger a longer-term improvement in rate of learning from each case. This should lead, in due course, to improvements in our ability to prevent fatal food anaphylaxis in children and young people.</p><p>S.S. wrote the original report and the first draft of the editorial. All authors edited and commented on the editorial and approved the final version.</p><p>R.J.B. declares payment for editorial work from Wiley and the British Society for Allergy and Clinical Immunology, consultancy payment from the World Health Organization, payment for work as a member of two UK Department of Health and Social Care expert advisory committees on nutrition, unpaid roles as a member of the UK Baby Feeding Law Group and a professional advisor to La Leche League, and payment for work as an expert witness in cases related to food anaphylaxis and cases related to infant formula health claims. The other authors declare no relevant conflict of interest.</p>","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":"55 1","pages":"4-7"},"PeriodicalIF":5.2000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cea.14614","citationCount":"0","resultStr":"{\"title\":\"Fatal Food Anaphylaxis in Children: A Statutory Review in England\",\"authors\":\"Sylvia Stoianova,&nbsp;Vibha Sharma,&nbsp;Robert J. Boyle\",\"doi\":\"10.1111/cea.14614\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Fatal anaphylaxis is a very rare, unpredictable tragedy. For children and young people, most fatal anaphylaxis is caused by food allergy, and thus, carers of children and young people with food allergy may become preoccupied about the possibility of sudden, unexpected fatal anaphylaxis. Other unexpected causes of death such as severe acute asthma are less rare than fatal anaphylaxis, but the rapidity of fatal food anaphylaxis and its propensity to affect adolescents and young adults generate continued concern and societal interest.</p><p>The burden of avoiding known food allergens falls largely on people living with allergies and their families. Thus, an exposure leading to a fatal anaphylactic reaction may inspire fear and guilt in families and also in other carers, caterers and health professionals. Most anaphylactic reactions to food self-revert, with or without medical intervention [<span>1</span>]. In the past 30 years, several society-wide changes have been made to try to prevent fatal food anaphylaxis. In many countries such as the UK, these include widespread provision of adrenaline autoinjectors, new food allergen labelling laws, increased food allergy diagnostics and improved emergency service awareness of anaphylaxis and its management [<span>2, 3</span>]. Yet, fatal food anaphylaxis remains as common as it was 30 years ago, suggesting we need to go back a step and learn more about the condition [<span>4</span>]. Fatal food anaphylaxis is difficult to study prospectively, because it is very rare, unpredictable and usually occurs in the community. It is therefore important that we learn as much as we can from each tragic occurrence, and the recent statutory review of childhood fatal anaphylaxis and asthma provides an opportunity to do this (Figure 1, Table 1).</p><p>England is one of very few countries with a national, statutory, multi-professional review of all child deaths [<span>5</span>]. Since 2019, the National Child Mortality Database (NCMD) collates and analyses information about child deaths. For all deaths under age 18, a comprehensive summary of the circumstances of death and background information from professionals is collated. A final record summarises conclusions of a multi-agency panel documenting contributory, modifiable factors and learning. The latest NCMD thematic report analysed child deaths in England because of asthma or anaphylaxis. It identified key findings and made recommendations for policy, practice and research [<span>6</span>].</p><p>The report documents 54 child deaths from asthma and 19 from anaphylaxis in a 4-year period from 1 April 2019 to 31 March 2023. Many (54%) of the children who died from asthma also had a food allergy. However, the cause of death in these cases was thought to be asthma rather than food anaphylaxis. Fatal anaphylaxis was triggered by food allergy (<i>n</i> = 18) and in one case by anaesthesia, a rare cause of fatal anaphylaxis in childhood [<span>7</span>]. Just over half of fatal anaphylactic events occurred at the child's home or another private residence (friend or relative's home), 26% occurred in a public place, 11% at school, one at hospital and one abroad. Just under half the children who died from food anaphylaxis attended an emergency department at least once in the year prior to their death. In 16% of emergency department attendances in the previous year, the primary diagnosis for the attendance was anaphylaxis and in 11% asthma. Twenty-one per cent of fatal anaphylaxis cases also had at least one emergency inpatient admission in the year prior to their death, in three cases for asthma. The child death review process was complete for 12 children with fatal food anaphylaxis. From the completed reviews, the causative food allergen was only established in nine cases, with cow's milk and nuts the commonest, consistent with previous findings. These data build on a previous analysis of fatal food anaphylaxis in the UK between 1998 and 2018, and show a similar event rate to those years [<span>8</span>]. Although it is not possible to directly compare both analyses, as the data sources were different, there is no obvious sign that the number of fatal food anaphylaxis cases is changing over time [<span>4</span>]. Cases remain rare, however what the national analysis of child deaths can add is the identification of potentially modifiable contributory factors that if addressed with local or national interventions, may prevent future deaths in similar circumstances. This is at the heart of the value that a standardised child death process aims to bring.</p><p>One of the most significant findings in the NCMD report is that all 18 cases of fatal food anaphylaxis occurred in children who were known to have asthma. Only about half of children with food allergy have asthma, so asthma appears to be an important risk factor for fatal food anaphylaxis. Bronchospasm is also a dominant feature of food anaphylaxis and is likely to play an important part in the pathophysiology of fatal food anaphylaxis. The report also found that ingestion of the relevant allergen was not obvious in most cases. So, an important learning point from the analysis is that anaphylaxis should always be considered in a child with asthma and a known food allergy who has sudden breathing difficulty. In the absence of careful enquiry considering the possibility of an allergic reaction preceding death, fatal anaphylaxis as the cause of death may be missed.</p><p>The most common, potentially modifiable factors in cases of fatal food anaphylaxis were poor asthma control, lack of formal asthma diagnosis, poor communication around allergies, poor record-keeping and information-sharing between professionals and lack of access to effective emergency treatment. Most (89%) of those where the food allergen trigger was clear already knew they were allergic to the trigger allergen. There was limited information recorded about adrenaline autoinjector (AAI) use. Although these may not be effective for preventing fatal anaphylaxis, they are the current standard for self-administered emergency management of anaphylaxis [<span>4</span>]. There was lack of understanding of the role of emergency medicines, lack of availability of in-date emergency medications and lack of understanding about when and how to use them.</p><p>The most common public safety factors which were identified related to unclear, misleading or inaccurate labelling of food, either packaged or cooked, purchased from supermarkets or takeaway shops. In one case, there was presumed contamination of a packaged food which was opened and served at a public venue. Food suppliers and those serving customers, must ensure compliance with food labelling and handling regulations. Mast cell tryptase can be normal in cases of fatal anaphylaxis. However, a paired sample of mast cell tryptase in the context of a clinical presentation of anaphylaxis, can be informative in supporting investigation. The report found that there were instances where the mast cell tryptase test was not checked, collected without information regarding time of sample collection or only collected at the time of the post-mortem examination, reducing its usefulness [<span>9</span>].</p><p>A final, important recommendation from the report is that for all cases of fatal anaphylaxis the Joint Agency Response (JAR) to Suspected Child Death from Anaphylaxis or Asthma guidance, which supplements standard JAR guidance, should be followed. This covers mast cell tryptase testing in cases of suspected anaphylaxis, forensic investigation of potential sources of allergen for testing and collection of food packaging where food allergy is a possible cause. JAR is a mechanism for investigating unexpected child death, and it includes medical and forensic investigations, environmental assessment and post-mortem examination. If the specific JAR guidance is followed, this will help us learn about fatal food anaphylaxis in a more systematic way, with a view to providing evidence-based advice for families and health professionals in the future.</p><p>In conclusion, this new report which summarises 4 years of fatal anaphylaxis data for children in England gives important insights. The report highlights potentially modifiable risks in terms of asthma recognition and management, and communication related to food allergens. There is no evidence for a recent change in event rate. But by calling for more thorough and systematic investigation of every case of fatal food anaphylaxis, the report has the potential to trigger a longer-term improvement in rate of learning from each case. This should lead, in due course, to improvements in our ability to prevent fatal food anaphylaxis in children and young people.</p><p>S.S. wrote the original report and the first draft of the editorial. All authors edited and commented on the editorial and approved the final version.</p><p>R.J.B. declares payment for editorial work from Wiley and the British Society for Allergy and Clinical Immunology, consultancy payment from the World Health Organization, payment for work as a member of two UK Department of Health and Social Care expert advisory committees on nutrition, unpaid roles as a member of the UK Baby Feeding Law Group and a professional advisor to La Leche League, and payment for work as an expert witness in cases related to food anaphylaxis and cases related to infant formula health claims. The other authors declare no relevant conflict of interest.</p>\",\"PeriodicalId\":10207,\"journal\":{\"name\":\"Clinical and Experimental Allergy\",\"volume\":\"55 1\",\"pages\":\"4-7\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-01-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cea.14614\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Allergy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cea.14614\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Allergy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cea.14614","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

致死性过敏反应是非常罕见的,不可预测的悲剧。对于儿童和年轻人来说,大多数致命的过敏反应是由食物过敏引起的,因此,患有食物过敏的儿童和年轻人的护理人员可能会对突然的、意外的致命过敏反应的可能性感到担忧。其他意外死亡原因,如严重急性哮喘,不如致死性过敏反应罕见,但致死性食物过敏反应的快速性及其影响青少年和年轻人的倾向,引起了持续的关注和社会兴趣。避免已知食物过敏原的负担主要落在过敏患者及其家人身上。因此,导致致命过敏反应的暴露可能会引起家庭以及其他护理人员、餐饮服务提供者和卫生专业人员的恐惧和内疚。大多数对食物的过敏反应,无论是否有医疗干预,都会自行恢复。在过去的30年里,为了防止致命的食物过敏反应,社会范围内发生了一些变化。在英国等许多国家,这些措施包括广泛提供肾上腺素自动注射器、新的食物过敏原标签法、增加食物过敏诊断和提高应急服务对过敏反应及其管理的认识[2,3]。然而,致命的食物过敏反应仍然和30年前一样普遍,这表明我们需要退后一步,更多地了解这种情况。致死性食物过敏反应非常罕见,难以预测,通常发生在社区,因此很难进行前瞻性研究。因此,重要的是我们要从每一起悲剧事件中尽可能多地学习,而最近对儿童致命过敏反应和哮喘的法定审查提供了一个这样做的机会(图1,表1)。英国是为数不多的对所有儿童死亡事件进行全国性、法定、多专业审查的国家之一。自2019年以来,国家儿童死亡率数据库(nmd)整理和分析了有关儿童死亡的信息。对于所有18岁以下的死亡,对死亡情况和专业人员提供的背景资料进行了综合总结。最终记录总结了多机构小组的结论,记录了促成因素、可改变因素和学习情况。最新的nmd专题报告分析了英格兰因哮喘或过敏反应而死亡的儿童。它确定了主要发现,并为政策、实践和研究提出了建议。该报告记录了2019年4月1日至2023年3月31日的4年期间,54名儿童死于哮喘,19名儿童死于过敏反应。许多(54%)死于哮喘的儿童也有食物过敏。然而,在这些病例中,死亡原因被认为是哮喘而不是食物过敏反应。致死性过敏反应由食物过敏引起(n = 18), 1例由麻醉引起,这是儿童bbb致死性过敏反应的罕见原因。超过一半的致死性过敏事件发生在儿童家中或其他私人住所(朋友或亲戚家中),26%发生在公共场所,11%发生在学校,1起发生在医院,1起发生在国外。在死于食物过敏反应的儿童中,不到一半的人在死前一年至少去过一次急诊室。在上一年的急诊就诊中,16%的患者的主要诊断是过敏反应,11%的患者的主要诊断是哮喘。在致死性过敏反应病例中,21%在死亡前一年至少有一次急诊住院,其中三例是哮喘病例。完成了12例致命性食物过敏反应儿童死亡审查过程。从已完成的审查中,仅在9例中确定了致病性食物过敏原,其中牛奶和坚果是最常见的,与之前的发现一致。这些数据建立在之前对1998年至2018年英国致命食物过敏反应的分析基础上,并显示出与那些年相似的事件发生率。虽然由于数据来源不同,不可能直接比较这两种分析,但没有明显迹象表明致命性食物过敏反应病例的数量随着时间的推移而变化。病例仍然很少,但是,对儿童死亡的国家分析可以补充的是,确定可能可改变的促成因素,如果通过地方或国家干预措施加以解决,可能会防止今后在类似情况下发生死亡。这是标准化儿童死亡程序旨在带来的价值的核心。ncdc报告中最重要的发现之一是,所有18例致命性食物过敏反应病例都发生在已知患有哮喘的儿童中。只有大约一半的食物过敏儿童患有哮喘,因此哮喘似乎是致命的食物过敏反应的重要危险因素。支气管痉挛也是食物过敏反应的主要特征,可能在致死性食物过敏反应的病理生理学中起重要作用。 该报告还发现,在大多数情况下,摄入相关过敏原并不明显。因此,从分析中得到的一个重要的教训是,对于患有哮喘和已知的食物过敏并突然出现呼吸困难的儿童,应始终考虑过敏反应。在没有仔细调查的情况下,考虑到死亡前过敏反应的可能性,致命的过敏反应可能会被遗漏。致死性食物过敏反应最常见的潜在可改变因素是哮喘控制不良、缺乏正式的哮喘诊断、过敏方面的沟通不良、专业人员之间的记录保存和信息共享不良以及缺乏有效的紧急治疗。大多数(89%)的食物过敏原触发者已经知道他们对触发过敏原过敏。关于肾上腺素自动注射器(AAI)使用的信息记录有限。虽然这些可能对预防致死性过敏反应无效,但它们是目前过敏反应自我管理紧急管理的标准。对紧急药物的作用缺乏了解,缺乏及时的紧急药物供应,对何时以及如何使用缺乏了解。被确定的最常见的公共安全因素与从超市或外卖店购买的包装或烹饪食品的标签不清楚、误导或不准确有关。在一起案件中,在公共场所打开并供应的包装食品被认为受到污染。食品供应商和为顾客服务的供应商必须确保遵守食品标签和处理规定。肥大细胞胰蛋白酶在致死性过敏反应中可能是正常的。然而,在过敏反应临床表现的背景下,肥大细胞胰蛋白酶的配对样本可以在支持调查中提供信息。报告发现,在某些情况下,肥大细胞胰蛋白酶测试没有进行检查,在收集样本时没有提供有关收集时间的信息,或仅在尸检时收集,从而降低了其用途。报告最后提出的一项重要建议是,对于所有致命性过敏反应病例,应遵循《过敏反应或哮喘导致疑似儿童死亡的联合机构应对指南》,该指南补充了标准的联合机构应对指南。这包括在疑似过敏反应病例中进行肥大细胞胰蛋白酶检测,对潜在过敏原来源进行法医调查以进行检测,以及收集可能导致食物过敏的食品包装。联合调查是一项调查意外儿童死亡的机制,包括医疗和法医调查、环境评估和尸检。如果遵循具体的JAR指南,这将有助于我们以更系统的方式了解致命的食物过敏反应,以期将来为家庭和卫生专业人员提供循证建议。总之,这份总结了英国儿童4年致死性过敏反应数据的新报告给出了重要的见解。该报告强调了哮喘识别和管理以及与食物过敏原相关的沟通方面可能改变的风险。没有证据表明最近的事件发生率发生了变化。但是,通过呼吁对每一个致命的食物过敏反应病例进行更彻底和系统的调查,该报告有可能引发从每个病例中吸取教训的比率的长期提高。这将在适当的时候提高我们预防儿童和年轻人致命食物过敏反应的能力。撰写了报告原文和社论初稿。所有作者都对社论进行了编辑和评论,并批准了最终版本。宣布从Wiley和英国过敏和临床免疫学学会获得的编辑工作报酬,从世界卫生组织获得的咨询报酬,作为两个英国卫生和社会保健部营养专家咨询委员会成员的工作报酬,作为英国婴儿喂养法律小组成员和国际母乳会专业顾问的无偿工作报酬,以及在食物过敏和婴儿配方奶粉健康声明相关案件中担任专家证人的报酬。其他作者声明无相关利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Fatal Food Anaphylaxis in Children: A Statutory Review in England

Fatal anaphylaxis is a very rare, unpredictable tragedy. For children and young people, most fatal anaphylaxis is caused by food allergy, and thus, carers of children and young people with food allergy may become preoccupied about the possibility of sudden, unexpected fatal anaphylaxis. Other unexpected causes of death such as severe acute asthma are less rare than fatal anaphylaxis, but the rapidity of fatal food anaphylaxis and its propensity to affect adolescents and young adults generate continued concern and societal interest.

The burden of avoiding known food allergens falls largely on people living with allergies and their families. Thus, an exposure leading to a fatal anaphylactic reaction may inspire fear and guilt in families and also in other carers, caterers and health professionals. Most anaphylactic reactions to food self-revert, with or without medical intervention [1]. In the past 30 years, several society-wide changes have been made to try to prevent fatal food anaphylaxis. In many countries such as the UK, these include widespread provision of adrenaline autoinjectors, new food allergen labelling laws, increased food allergy diagnostics and improved emergency service awareness of anaphylaxis and its management [2, 3]. Yet, fatal food anaphylaxis remains as common as it was 30 years ago, suggesting we need to go back a step and learn more about the condition [4]. Fatal food anaphylaxis is difficult to study prospectively, because it is very rare, unpredictable and usually occurs in the community. It is therefore important that we learn as much as we can from each tragic occurrence, and the recent statutory review of childhood fatal anaphylaxis and asthma provides an opportunity to do this (Figure 1, Table 1).

England is one of very few countries with a national, statutory, multi-professional review of all child deaths [5]. Since 2019, the National Child Mortality Database (NCMD) collates and analyses information about child deaths. For all deaths under age 18, a comprehensive summary of the circumstances of death and background information from professionals is collated. A final record summarises conclusions of a multi-agency panel documenting contributory, modifiable factors and learning. The latest NCMD thematic report analysed child deaths in England because of asthma or anaphylaxis. It identified key findings and made recommendations for policy, practice and research [6].

The report documents 54 child deaths from asthma and 19 from anaphylaxis in a 4-year period from 1 April 2019 to 31 March 2023. Many (54%) of the children who died from asthma also had a food allergy. However, the cause of death in these cases was thought to be asthma rather than food anaphylaxis. Fatal anaphylaxis was triggered by food allergy (n = 18) and in one case by anaesthesia, a rare cause of fatal anaphylaxis in childhood [7]. Just over half of fatal anaphylactic events occurred at the child's home or another private residence (friend or relative's home), 26% occurred in a public place, 11% at school, one at hospital and one abroad. Just under half the children who died from food anaphylaxis attended an emergency department at least once in the year prior to their death. In 16% of emergency department attendances in the previous year, the primary diagnosis for the attendance was anaphylaxis and in 11% asthma. Twenty-one per cent of fatal anaphylaxis cases also had at least one emergency inpatient admission in the year prior to their death, in three cases for asthma. The child death review process was complete for 12 children with fatal food anaphylaxis. From the completed reviews, the causative food allergen was only established in nine cases, with cow's milk and nuts the commonest, consistent with previous findings. These data build on a previous analysis of fatal food anaphylaxis in the UK between 1998 and 2018, and show a similar event rate to those years [8]. Although it is not possible to directly compare both analyses, as the data sources were different, there is no obvious sign that the number of fatal food anaphylaxis cases is changing over time [4]. Cases remain rare, however what the national analysis of child deaths can add is the identification of potentially modifiable contributory factors that if addressed with local or national interventions, may prevent future deaths in similar circumstances. This is at the heart of the value that a standardised child death process aims to bring.

One of the most significant findings in the NCMD report is that all 18 cases of fatal food anaphylaxis occurred in children who were known to have asthma. Only about half of children with food allergy have asthma, so asthma appears to be an important risk factor for fatal food anaphylaxis. Bronchospasm is also a dominant feature of food anaphylaxis and is likely to play an important part in the pathophysiology of fatal food anaphylaxis. The report also found that ingestion of the relevant allergen was not obvious in most cases. So, an important learning point from the analysis is that anaphylaxis should always be considered in a child with asthma and a known food allergy who has sudden breathing difficulty. In the absence of careful enquiry considering the possibility of an allergic reaction preceding death, fatal anaphylaxis as the cause of death may be missed.

The most common, potentially modifiable factors in cases of fatal food anaphylaxis were poor asthma control, lack of formal asthma diagnosis, poor communication around allergies, poor record-keeping and information-sharing between professionals and lack of access to effective emergency treatment. Most (89%) of those where the food allergen trigger was clear already knew they were allergic to the trigger allergen. There was limited information recorded about adrenaline autoinjector (AAI) use. Although these may not be effective for preventing fatal anaphylaxis, they are the current standard for self-administered emergency management of anaphylaxis [4]. There was lack of understanding of the role of emergency medicines, lack of availability of in-date emergency medications and lack of understanding about when and how to use them.

The most common public safety factors which were identified related to unclear, misleading or inaccurate labelling of food, either packaged or cooked, purchased from supermarkets or takeaway shops. In one case, there was presumed contamination of a packaged food which was opened and served at a public venue. Food suppliers and those serving customers, must ensure compliance with food labelling and handling regulations. Mast cell tryptase can be normal in cases of fatal anaphylaxis. However, a paired sample of mast cell tryptase in the context of a clinical presentation of anaphylaxis, can be informative in supporting investigation. The report found that there were instances where the mast cell tryptase test was not checked, collected without information regarding time of sample collection or only collected at the time of the post-mortem examination, reducing its usefulness [9].

A final, important recommendation from the report is that for all cases of fatal anaphylaxis the Joint Agency Response (JAR) to Suspected Child Death from Anaphylaxis or Asthma guidance, which supplements standard JAR guidance, should be followed. This covers mast cell tryptase testing in cases of suspected anaphylaxis, forensic investigation of potential sources of allergen for testing and collection of food packaging where food allergy is a possible cause. JAR is a mechanism for investigating unexpected child death, and it includes medical and forensic investigations, environmental assessment and post-mortem examination. If the specific JAR guidance is followed, this will help us learn about fatal food anaphylaxis in a more systematic way, with a view to providing evidence-based advice for families and health professionals in the future.

In conclusion, this new report which summarises 4 years of fatal anaphylaxis data for children in England gives important insights. The report highlights potentially modifiable risks in terms of asthma recognition and management, and communication related to food allergens. There is no evidence for a recent change in event rate. But by calling for more thorough and systematic investigation of every case of fatal food anaphylaxis, the report has the potential to trigger a longer-term improvement in rate of learning from each case. This should lead, in due course, to improvements in our ability to prevent fatal food anaphylaxis in children and young people.

S.S. wrote the original report and the first draft of the editorial. All authors edited and commented on the editorial and approved the final version.

R.J.B. declares payment for editorial work from Wiley and the British Society for Allergy and Clinical Immunology, consultancy payment from the World Health Organization, payment for work as a member of two UK Department of Health and Social Care expert advisory committees on nutrition, unpaid roles as a member of the UK Baby Feeding Law Group and a professional advisor to La Leche League, and payment for work as an expert witness in cases related to food anaphylaxis and cases related to infant formula health claims. The other authors declare no relevant conflict of interest.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.40
自引率
9.80%
发文量
189
审稿时长
3-8 weeks
期刊介绍: Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.
期刊最新文献
A Meta-Analysis of Anti-Thyroid Peroxidase Antibody and Omalizumab Response in Chronic Spontaneous Urticaria. Asthma Incidence and Risk Factors in Tuberculosis Survivors: A Longitudinal Analysis of National Health Data. Worldwide Impact of Human Development and Inequality on the Prevalence of Asthma, Rhinoconjunctivitis and Eczema. Global Asthma Network's Ecological Study. Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis. Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1